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native method for inoculation of laboratory animals or the
use of speciﬁc culture media for routine plaque surveillance
and outbreak investigations.
doi:10.1016/j.ijid.2010.02.427
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anthracis from environmental samples
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Background: Bacillus anthracis, the causative agent of
anthrax is a major concern of a dangerous and zoonotic
disease in medicine and veterinary medicine. The develop-
ment of rapid, sensitive and simple techniques to detect
B.anthracis in suspicious specimens is the important aim of
animals and subsequently public health. we described a mul-
tiplex PCR system with application of IPC (internal positive
control) for detecting virulence markers in B.anthracis.
Methods: In PCR assay pag and cap genes located on POX1
and POX2 plasmids were ampliﬁed by use of speciﬁc primers.
In order to control of reaction conditions, we used from PCR
products as a templet and designed IPC for pag and cap genes
that their length was shorter than product segments. After
cloning of PCR products, the sensitivity of the PCR test (limit
of detection) was also estimated. Control bacteria of deﬁned
species was conﬁrmed by ampliﬁcation of a fragment of the
16S rRNA gene by using two universal primers.
Results: In post-PCR stage 591 and 173 bp fragments
of DNA respectively to cap and pag genes recognized in
agarose gel. Sensitivity determination assays revealed that
this method can detect, 412 and 100 copies as LOD for cap
and pag gene respectively in samples.Nonetheless, bands on
the results with negative controls, these genes not present
in these deﬁned bacteria.
Conclusion: In this study, we desigined and optimized a
multiplex PCR assay for the detection and characterization
of B.anthracis from environmental samples. In addition to
we used from IPC to prevention of false negative results and
also to detect inhibitory effects of the sample matrix. The
PCR system described here can be proposed as rapid, safe,
diagnostic and conﬁdent method for detecting anthrax. The
sensitive and speciﬁc nature of this assay provides a valu-
able tool that can be used for analysing clinical and ﬁeld
samples and for improving our understanding of the ecology
and environmental prevalence of B.anthracis in natural foci
of disease.
doi:10.1016/j.ijid.2010.02.428
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B test-kit for rapid drug susceptibility testing ofM. tuber-
ulosis
. Domotenko ∗, M. Khramov
State Research Center for Applied Microbiology & Biotech-
ology, Obolensk, Russian Federation
Background: Drug resistant tuberculosis is an increasing
ublic health concern in many parts of the world, includ-
ng Russia. Traditional drug susceptibility testing is either
ime-consuming (21—28 days for the absolute concentra-
ion method) or expensive (automatic BACTEC systems). In
ontrast, TB test-kit developed at SRCAMB (in the frame of
TEP/DHHS projects #2 and 86) allows for reducing the time
f testing in 2.5 times, has low price and can be used in all
he bacteriological labs.
Methods: Drug susceptibility testing with TB test-kit is
ased on the ability of M. tuberculosis to reduce nitrates
o nitrites. The nitrites are detected with Griess reagent,
hich produces a color change. Sputum or suspension of M.
uberculosis strains inoculates into each a vial of the test-
it with syringe. Then vials of inoculated media incubate at
35± 2) ◦C. In 8—13 days of incubation resistant isolates of
. tuberculosis produce color changes in the vial with an
ppropriate drug. Susceptible isolates does not produce a
olor change.
Results: TB test - kit is a kit of ready-for-use nutrient
edia with drugs or without them and reagent for read-
ng results. The test-kit allows to determine susceptibility
f M. tuberculosis to isoniazid, rifampicin, streptomycin,
thambutol and to perform primary identiﬁcation of M.
uberculosis. The SRCAMB TB test-kit have been tested in
hree clinical laboratories in Russia in comparison with the
bsolute concentration method and the automated BACTEC
GIT 960 using about one thousand M. tuberculosis isolates.
ood agreement between the results of TB test kit and two
echniques was found. In 2008, the RF Ministry of Health
pproved the TB-test kit for production, sale and distribu-
ion at Russian Federation. TB test-kit is currently being
anufactured in SCRAMB and sold by small lots. The basic
onsumers of TB test - kit are mycobacteriological labora-
ories.
Conclusion: Performance of testing with the test-kit does
ot require special equipment and highly skilled personnel.
oi:10.1016/j.ijid.2010.02.429
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roduction and standardization of Brucella national stan-
ard antiserum equivalent to OIEISS in Sudan
.F.E.M. Alawad1,∗, M.T. Musa2
Animal Resources Research corporation, Central
et.Research lab.(CVRL) -Soba, Khartoum, Sudan
Animal Resources Research Corporation, Khartoum, Sudan
Background: Brucellosis is a bacterial contagious zoonotic
isease caused by one of the ninth species of the genus
rucella, including the three proposed new species Brucella
eti, B.pinnipedis (Foster et al., 2002, 2007) and B.microti
Scholz et al., 2008a, 2008b). The serological tests were
